Marconato, M., Kauer, J., Salih, H. R., Märklin, M., & Heitmann, J. S. (2022). Expression of the immune checkpoint modulator OX40 indicates poor survival in acute myeloid leukemia. Scientific reports, 12, . https://doi.org/10.1038/s41598-022-19972-1
Chicago Style (17th ed.) CitationMarconato, Maddalena, Joseph Kauer, Helmut R. Salih, Melanie Märklin, and Jonas S. Heitmann. "Expression of the Immune Checkpoint Modulator OX40 Indicates Poor Survival in Acute Myeloid Leukemia." Scientific Reports 12 (2022). https://doi.org/10.1038/s41598-022-19972-1.
MLA (9th ed.) CitationMarconato, Maddalena, et al. "Expression of the Immune Checkpoint Modulator OX40 Indicates Poor Survival in Acute Myeloid Leukemia." Scientific Reports, vol. 12, 2022, https://doi.org/10.1038/s41598-022-19972-1.